Measurements of Myocardial Relaxation Time by MRI During Respiration
ARTEMIS
1 other identifier
interventional
9
1 country
1
Brief Summary
Measurement of T2 transversal relaxation time by magnetic resonance has a major interest in cardiac imagery. It has been initially used for quantitative evaluation of heart viability and more recently for edema characterization. It allows to prematurely detect a cardiac transplant rejection. This technique needs successively around ten FSE sequences during apnea. Weak reproducibility of successive apneas and discomfort of patient limit the precision of this measurement and consequently its use in standard care. The ARTEMIS study method allows the examination during free respiration without prolonging the duration of examination compared to the examination during apnea. Moreover, image processing is simplified and correction of respiratory movements renders results more reliable. This is a pilot study of evaluation of ARTEMIS technique of image reconstruction. ARTEMIS is a method of MRI image reconstruction for measurements of T2 transversal relaxation. It allows to obtain diagnostic images without movement artifacts. The primary objective si to show the feasibility of ARTEMIS method for measurement of myocardial T2 relaxation time during free respiration in cardiac transplant patients. The secondary objective is to collect quantitative data to compare ARTEMIS method of measurement of T2 during free respiration and standard clinical practice during apnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 31, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2012
CompletedFirst Submitted
Initial submission to the registry
July 26, 2017
CompletedFirst Posted
Study publicly available on registry
July 31, 2017
CompletedAugust 3, 2017
July 1, 2017
1.3 years
July 26, 2017
August 2, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Image quality assessed y senior radiologists
baseline
Movement correction in images assessed by senior radiologists
baseline
Secondary Outcomes (1)
Quantitative measurement of myocardial transversal relaxation time in 6 segments of short median axe cross-section of left ventricle in standard and ARTEMIS images
baseline
Study Arms (1)
MRI scan during free respiration
EXPERIMENTALInterventions
MRI standard protocol with addition of: * a second clinical respiratory belt besides belt usually installed for clinical examination * a second clinical electrocardiogram sensor besides sensor usually installed for clinical examination * 12 sequences during free respiration are added lasting supplementary 15 minutes * Use of cardiac antennae usually used for cardiac MRI scans
Eligibility Criteria
You may qualify if:
- To have had a heart transplant, whenever
- To have an MRI scan of heart with measurement of T2 relaxation time (whatever the reason for examination)
- Major
- To be aware and cooperative
- Affiliation to social security plan
- To have given written consent after having received oral and written, clear and intelligible information
You may not qualify if:
- All contraindications to MRI (implantable defibrillator, cochlear implant, neurosurgical clip, intraorbital or encephalic metallic foreign body, endoprosthesis installed since less than 4 weeks, osteosynthesis materials installed since less than 6 weeks…)
- Instable hemodynamic status, acute respiratory failure, uncertain general status or necessity of continuous monitoring incompatible with MRI examination
- Minors or being under juridical protection or absence of social security
- Refusal or impossibility of informed consent of patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Nancy Brabois
Vandœuvre-lès-Nancy, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2017
First Posted
July 31, 2017
Study Start
August 31, 2011
Primary Completion
December 19, 2012
Study Completion
December 19, 2012
Last Updated
August 3, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share